These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacokinetics of piroxicam in man. Hobbs DC Eur J Rheumatol Inflamm; 1983; 6(1):46-55. PubMed ID: 6861813 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of piroxicam, a new nonsteroidal anti-inflammatory agent, under fasting and postprandial states in man. Ishizaki T; Nomura T; Abe T J Pharmacokinet Biopharm; 1979 Aug; 7(4):369-81. PubMed ID: 512843 [TBL] [Abstract][Full Text] [Related]
4. The effects of food and of antacid on the single oral dose pharmacokinetics of tenoxicam. Francis RJ; Dixon JS; Lowe JR; Harris PA Eur J Drug Metab Pharmacokinet; 1985; 10(4):309-14. PubMed ID: 3879481 [TBL] [Abstract][Full Text] [Related]
5. The effect of administration of propranolol on the pharmacokinetics of isoxicam. Caillé G; Larivière L; Lacasse Y; Vézina M; Besner JG Biopharm Drug Dispos; 1986; 7(1):63-9. PubMed ID: 3955200 [TBL] [Abstract][Full Text] [Related]
6. Metabolism of piroxicam by laboratory animals. Hobbs DC; Twomey TM Drug Metab Dispos; 1981; 9(2):114-8. PubMed ID: 6113108 [TBL] [Abstract][Full Text] [Related]
7. Interaction of isoxicam with acetylsalicylic acid. Esquivel M; Cussenot F; Ogilvie RI; East DS; Shaw DH Br J Clin Pharmacol; 1984 Oct; 18(4):567-71. PubMed ID: 6487496 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiinflammatory activity of metabolites of piroxicam. Lombardino JG J Med Chem; 1981 Jan; 24(1):39-42. PubMed ID: 7205872 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic observations on piroxicam in young adult, middle-aged and elderly patients. Woolf AD; Rogers HJ; Bradbrook ID; Corless D Br J Clin Pharmacol; 1983 Oct; 16(4):433-7. PubMed ID: 6626437 [TBL] [Abstract][Full Text] [Related]
11. The effect of antacid and aspirin on the bioavailability of isofezolac in man. Rocher I; Henry JF; Flouvat B Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):464-9. PubMed ID: 6500763 [TBL] [Abstract][Full Text] [Related]
12. Effect of impairment of renal function on the accumulation and disposition of isoxicam. Bury RW; Whitworth JA; Saines D; Kincaid-Smith P; Moulds RF Eur J Clin Pharmacol; 1985; 28(5):585-8. PubMed ID: 4043201 [TBL] [Abstract][Full Text] [Related]
13. Single-dose and steady-state pharmacokinetics of piroxicam in elderly vs young adults. Darragh A; Gordon AJ; O'Byrne H; Hobbs D; Casey E Eur J Clin Pharmacol; 1985; 28(3):305-9. PubMed ID: 4007035 [TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal anti-inflammatory agents. A review of the literature. Kollenberg LO; Hudyma EO; Robbins JM J Am Podiatr Med Assoc; 1985 Oct; 75(10):517-22. PubMed ID: 4057061 [No Abstract] [Full Text] [Related]
15. The effect of activated charcoal on the bioavailability of piroxicam in man. Laufen H; Leitold M Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):48-52. PubMed ID: 3957490 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of droxicam in rat and dog. Esteve A; Martínez L; Roser R; Sagarra R Methods Find Exp Clin Pharmacol; 1986 Jul; 8(7):423-9. PubMed ID: 3762266 [TBL] [Abstract][Full Text] [Related]
17. The topical anti-inflammatory effects of piroxicam in rodents. Larson DL; Lombardino JG Agents Actions; 1980 Jun; 10(3):246-51. PubMed ID: 7405751 [TBL] [Abstract][Full Text] [Related]
19. [Inter- and intra-individual variations on the disposition of piroxicam. Pharmacokinetics in healthy man and the patient with renal insufficiency]. Dupont D; Dayer P; Balant L; Gorgia A; Fabre J Pharm Acta Helv; 1982; 57(1):20-6. PubMed ID: 7058201 [No Abstract] [Full Text] [Related]
20. The energetics of the interaction of piroxicam with plasma albumin. Oyekan AO; Thomas WO J Pharm Pharmacol; 1984 Dec; 36(12):831-4. PubMed ID: 6151976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]